SUD patients before and during the COVID-19 pandemic.
收藏数据链接：
官方服务：
资源简介：
SUD patients before and during the COVID-19 pandemic.
应用场景：
创建时间：
2024-10-24
相关数据集
Substance use disorders: incidence, prevalence, deaths and DALY's, in 1990-2017
Datasets from Global Burden of Diseases Study 2019. Mortality, morbidity, prevalence, from use of tobacco, alcohol, opiates, cannabis, and other drugs, the aggregated indicator (Substance use disorder
NIAID Data Ecosystem90
The global substance use disorder treatment market size will be USD 41215.2 million in 2024.
According to Cognitive Market Research, the global Substance Use Disorder Treatment market size will be USD 41215.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.50% fro
www.cognitivemarketresearch.com70
Bayesian Poisson regression spatial analysis of the associations between county-level covariates and the relative risk (RR) of death by Substance Use Disorders (SUD).
Bayesian Poisson regression spatial analysis of the associations between county-level covariates and the relative risk (RR) of death by Substance Use Disorders (SUD).
NIAID Data Ecosystem30
Supplementary Material for: ESCAPE study: Cannabidiol use in patients treated for substance use disorders, prevalence of use and characteristics of users.
Introduction: Cannibidiol (CBD) is one of the two primary phytocannabinoids found in cannabis. Its diverse pharmacological properties suggest potential benefits for a wide range of medical conditions.
DataCite Commons2024-12-20 更新80
HAIS scoring at first and fourth session of EFPP.
Equine Facilitated Psychiatry and Psychology (EFPP) is a supportive non-pharmacological treatment program used in the treatment of patients with substance use disorder. The aim of this study was to ev
Figshare2023-06-28 更新40
